Generate a tailored SOP for Dr. Gregory Redpath. Improve your application with a focused, well-structured draft.
Gregory Redpath is an Associate Group Leader in the Department of Molecular Medicine at the School of Biomedical Sciences. His research focuses on cell biology and receptor trafficking, specifically the role of serotonin receptor signaling in cardiovascular disease, depression, and anxiety. Gregory completed his Bachelor of Science with Honours in Biochemistry at the University of Otago from 2007 to 2010, followed by a PhD at the University of Sydney from 2011 to 2016. He then undertook a postdoctoral position at the University of New South Wales and the University of Otago, developing advanced live cell imaging techniques to dissect mechanisms of cellular processes that underpin health. His current research aims to uncover the molecular mechanisms by which psychedelics act, leading to potential treatments for depression and anxiety. This includes identifying the therapeutic potential of psilocybin-related compounds sourced from mushrooms, as well as investigating how serotonin signaling intersects with the development of cardiovascular disease. Gregory is dedicated to conducting culturally guided molecular research to integrate meaningful data outcomes within indigenous communities.
Department of Molecular Medicine, School of Biomedical Sciences • Sydney, Australia
Leading research on serotonin receptor signaling and its implications in cardiovascular health.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.